Navigation Links
Decision Diagnostic Corp. Clarifies 10% Stock Dividend, Announces Patent Enforcement Strategy

LOS ANGELES, Dec. 27, 2011 /PRNewswire/ -- Decision Diagnostics Corp., formerly known as InstaCare Corp., (OTCQB: ISCRD), a leading provider of prescription diagnostics, home testing products for the chronically ill, a leading fulfillment provider of direct to patient diabetes programs, and a leading developer of revolutionary cell phone centric e-health products and technologies, today announced that its previously announced 10% Stock Dividend will be Ex-Dividend to all shareholders of record on December 28, 2011.  The Dividend payment date will be December 30, 2011.

Mr. Berman, CFO and Secretary commented, "the stock Dividend is designed to enhance the visibility of the company, improve liquidity, and reward our loyal shareholders.  This Dividend and the changes to the company's capital structure are part of an effort to qualify to have our common stock to be listed on a national exchange, with the goal of applying to the NASDAQ Bx exchange in 2012."

Decision Diagnostics also announced that the company acquired another small engineering oriented company, Sensor Concepts, LLC, an electro-chemistry concepts company.  In addition, the company announced that they have formulated a patent enforcement strategy to coincide with the expected near term grant of the patent for the company's MD@Hand technologies.

Mr. Berman continued, "the Board will continue to evaluate other acquisitions that would add to the company's depth in the at-home diagnostics channel, while we conclude the FDA 510k approval process for Shasta Genstrip. We will have more to say about our new patent enforcement strategies in the coming days."

For more information about Decision Diagnostics Corp. and its revolutionary MD@Hand cell phone centric technologies, and, Pharma Tech Solutions, Inc. and its Shasta Genstrip, please visit the Decision Diagnostics web site or the Pharma Tech web site, or call the company at (805) 446-2973.

Forward-Looking Statements

This news release contains forward-looking statements about our business, or financial condition and prospects that reflect our assumptions and beliefs based on information currently available. We can give no assurance that the expectations indicated by such forward-looking statements will be realized. There may be other risks and circumstances that we are unable to predict. When used in this news release, words such as "believes," "expects," "intends," "plans," "anticipates," "estimates" and similar expressions are intended to identify forward-looking statements, although there may be certain forward-looking statements not accompanied by such expressions.

SOURCE Decision Diagnostics Corp.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Catholic Health Association Applauds HHS Decision on Plan B
2. Decision Diagnostic Corp. (Formerly InstaCare) Announces 10% Stock Dividend
3. FDA Commissioner announces Avastin decision
4. Sanofi Pasteur Launches Nationwide Education Campaign to Help Parents Make Informed Decisions about Immunization
5. Pharmaceutical Executives Use New Search Function for Data-Informed Decision-Making
6. e-Zassi and UBM Canon Partner to Provide Online Medical Device Decision Support Tools at
7. American College of Medical Genetics Applauds HHS Secretarys Decision to Expand Newborn Screening to Include Critical Congenital Heart Disease
8. Experis Recognizes National Healthcare IT Week, Provides Tips for ICD-10 Assessment Decision
9. QIAGEN Completes Second U.S.Submission for Companion Diagnostic to Guide Treatment Decisions in Colorectal Cancer
10. DecisionView StudyOptimizer 4.3™ Enhances Market-Leading Enrollment Optimization Solution With Greater Visibility Into Site Performance and Cost Forecasting
11. Watson Confirms Favorable Appeals Court Decision in Mucinex(R) Patent Suit
Post Your Comments:
(Date:11/25/2015)... Developmental, commercial, and regulatory/legal strategies ... products, says GBI Research . ... all play a key role in boosting the profitability of ... --> Developmental, commercial, and regulatory/legal ... profitability of pharmaceutical products, says GBI Research ...
(Date:11/24/2015)... 2015 The hope of bearing ... of IVF cycles. After failure of over 15 IVF ... lost all hopes that she would be able to conceive ever. But finally optimism prevailed ... after failure of over 15 IVF cycles. ... to take one last attempt with Gaudium IVF Center in ...
(Date:11/24/2015)... HILL, N.C. , Nov. 24, 2015  In ... research projects in an effort to quickly uncover new ... position. --> --> ... launch a market research project and ensure that all ... company and industry standards. Another major barrier to efficiently ...
Breaking Medicine Technology:
(Date:11/25/2015)... , ... November 25, 2015 , ... On November 23rd ... Tri Lite’s personal heating products business. Cozy Products explains what this means ... that fit in well with the Cozy Products business model: to sell personal heaters ...
(Date:11/25/2015)... ... ... SCOTTSDALE, AZ) - Today, Dr. Todd C. Hobgood ... non-surgical treatments, announced the expansion of his private practice capabilities with the grand ... trained and nationally recognized for his natural approach, Dr. Todd Hobgood serves the ...
(Date:11/25/2015)... ... November 25, 2015 , ... Brillianteen, McGaw YMCA’s student-produced musical ... its 65th Anniversary Brillianteen Revue, scheduled for March 4-6, 2016. Auditions for this ... Brillianteen has been a treasured tradition for numerous families in the Evanston community. ...
(Date:11/25/2015)... ... November 25, 2015 , ... “While riding the bus, I saw a passenger ... thought there had to be a convenient and comfortable way to protect them from ... disabled individuals to safely travel during cold or inclement weather. In doing so, it ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... provide scholarships for people struggling with eating disorders as a result of the ... second annual event, held at Fox Run Golf Club in Eureka, will help ...
Breaking Medicine News(10 mins):